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SUMMARY
Eighteen clinically healthy dogs weighing 10-15 kg body weight were used in this study over a 20-day period.
They were allocated randomly into 3 groups of 6 animals each. After the creation of 5 cm x 5cm open wound, Group
I was control treated with Gentamycin ointment. Groups II and ill were treated with keratin-gelatin and basic fibroblast
growth factor (bFGF)-gelatin composite film respectively. On application, the keratin-gelatin and bFGF-gelatin com-
posite film were well accepted by the animals without any adverse reaction. On clinical examination, Group II showed
bright beefy red color granulation tissue with angiogenesis when compared to Groups I and ill.On bacteriological
examination, Staphylococcus aureus, Pseudomonas, Escherichia coli, Proteus and Klebsiella species were isolated
from all the groups. Mean percentage of epithelialisation, wound contraction and total healing were significantly
better in Group II (P<0.05). Keratin is a biocompatible protein which does not interfere with the body's normal
immunologic response and therefore it can be used in extensive wounds and also in non healing chronic wounds
which need a trigger to stimulate the normal healing process. In extensive wounds when there is lack of autologous
tissue, biomaterials like keratin-gelatin may be beneficial and can be used.
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INIRODUCTION
A wound arises due to disruption of the normal
architecture of a tissue. Wound healing occurs as a fun-
damental response to tissue injury (Sumitra et al., 2005).
The main objectives of any wound management are: func-
tional and cosmetic repair, relief of pain and distress to
the animal, economic and time efficient procedures and
prompt decision making in the event of signs of delayed
healing (Anderson, 1996). A major drawback in conven-
tional dressing materials, mainly composed of gauze, is
the adherence between the fibres of the gauze materials
and the tissue. Separation between the dressing material
and the tissue becomes very difficult (Lin et al., 2000).
Immediate wound coverage with native skin is pos-
sible only if sufficient donor area is available. Due to
lack of autologous tissue, the necrotised areas of large
burns must be covered by skin substitutes (Wisser and
Steffes, 2003). In large wound cases, if there is no re-
quired donor site available, biomaterials like synthetic
or natural polymers and their composites can be used as
a temporary closure of wounds (Babu et al., 1996).
Biomaterials like keratin and bFGF-gelatin composite film
can be used. Keratin is a fibrous protein that can be used
as an absorbent therapeutic material for skin and for cos-
metic applications. Hard keratins are a specialised type
of keratin found in feathers, hair, nails, wool and hooves
(Barone et al., 2005). Anderson et al. (2003) used
keratinocyte cultured epithelial auto graft for a dog with
severe bum injury. Basic Fibroblast Growth Factors
(bFGF) induce mitogenesis and play an important role in
wound healing. It is well known that bFGF promote
proliferation of almost all cells associated with wound
healing (Michiyo et al., 2005). Ono (2002) used bFGF to
promote wound healing. This study is done to assess
the effects of keratin hydrolysates of poultry feathers
prepared by controlled alkaline hydrolysis (Sehgal et al.,
1986) and bFGF- gelatin composite films on wound heal-
ing in experimental dogs.
MATERIALSANDMETIIODS
Animal subjects
Eighteen clinically healthy dogs weighing 10-15 kg
body weight were used in this study. They were allocated
randomly into 3 groups of 6 animals each. All the animals
were fed with dry food, and water was provided ad libi-
tum. Experimental subjects were given a thorough body
wash one day before surgery. Treatment allocation was
as described in the following pattern.
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Group I: (n=6). Control Group. Gentamycin ointment
(Dutch farm Veterinary pharmaceuticals, Netherlands)
was applied after creation of 5 cm x Scm open wound.
GROUP II: (n=6). Keratin-gelatin composite film
treated Group. The Scm x Scm open wound was treated
using 0.2mm thickness of keratin - gelatin film (361lg/cm2)
soaked for 1-2 minutes in gentamycin (Dutch farm Veteri-
nary pharmaceuticals, Netherlands).
GROUP ID: (n=6). The bFGF-gelatin composite film
treated Group. The Scm x Scm open wound was treated
using bFGF-gelatin composite film (0.0ISIlg/cm2) soaked
for 1-2 minutes in gentamycin (Dutch farm Veterinary
pharmaceuticals, Netherlands).
Wound dressing, clinical observation, wound
planimetery and bacteriological evaluation of wound for
all groups were done on days 4,8, 12, 16 and day 20.
Elizabethan collar was applied to prevent self-mutilation
of the surgical site.
Surgical protocol
On day 0, animals were pre-medicated with
Acepromazine (O.lmg/kg body wt SIC) and Atrophine
sulphate (O.OSmglkg body wt, Troy Laboratories, Aus-
tralia). Induction was done with 2.5 % Thiopentone so-
dium (12.5 mg/kg body weight IV, Troy Laboratories,
Australia) and maintained with Halothane (Troy Labora-
tories, Australia) in oxygen delivered via T-piece circuit
using cuffed endotracheal tube.
Animals were positioned in lateral recumbency and
the lower lateral aspect of the lumbosacral region in the
upper flank area was prepared for aseptic surgery for
creation of open wound. The skin was disinfected with
hibiscrub, containing 0.6% chlorohexidin then with 70 %
alcohol solution and with 2% iodine solution (Druecke
etal.,2004)
Using a sterile millimetre ruler and cotton tipped
applicator dipped in sterile methylene blue, Scm x Scm
square was drawn on the skin. A full thickness skin de-
fect in which all tissue down to and including the pan-
niculus muscle was excised using no. 15 scalpel blade.
Clinical observation
The colour of the wound bed gives an indication of
the phase of healing. Colour coding taken into account
are red, yellow, black and pink areas as the main vari-
ables in a wound. Shiny beefy red or red indicates healthy
granulation tissue. Yellow colour is due to fibrous tis-
sue or necrotic slough, black is eschar or necrotic tissue
and pink or purple means re-epithelialisation has begun.
(James and Bayat, 2003)
Odour: Mal-odour of the wound is commonly asso-
ciated with infection or attributed to poor hygiene or from
a dressing that has not been changed regularly. Presence
of necrotic tissue gives off an offensive repulsive odour,
and anaerobes typically produce a distinctive or putrid
odour (James and Bayat, 2003).
Exudate: Exudates can be scored as no exudates,
moderate or excessive. Type of discharge can be described
as serous (clear fluid without blood), pus or debris. Sero-
sanguinous and sanguinous indicates thin watery pale
red to pink fluid and bloody to bright red respectively.
Purulent discharge is thick, cloudy, and yellow or tans
(James and Bayat, 2003).
. A more accurate method of determining the wound
area in healing studies is tracing of the wound margins
onto a clear plastic film. In this method, a double layer
sterile plastic sandwich bag is placed on the wound for
tracing wound margins; the layer that contacts with the
wound can be removed and disposed and the outer layer
is placed on the graph sheet and the area is measured by
square counting procedure. The number of squares (0.25
cm') that lay completely (N) and partially (N) inside
the tracing are counted and area is determined using the
following formula: Ae+p= (Ne+ 0.40 x Np) x 0.25. (Richard
et al., 2000). The wound margin at the border between
normal skin and the wound and the outlined area is con-
sidered to be the total wound area. Next, the leading
edge of advancing epithelium is traced. The area between
these two margins is considered to be the area for
epithelialisation. The area within the margin of advanc-
ing epithelium is the area of open or unhealed wound
(Bohling etal.,2004):
Calculation of wound healing
Percentage of epithelialisation
Percentage of epithelialisation day D=
Area of epithelium day D X 100
Total wound area day D
Percentage of wound contraction
Step 1:Total wound on day D as % of original
= Total wound area day D X 100
Original wound area day,
Step 2: % wound contraction day D= 100- total wound on
day D as% of original
Percentage of total wound healing was calculated by
Step 1:open wound day D as % of original
= Open wound area day D X 100
Original wound area (day J
Step 2: % of total wound healing day D
= 100- open wound day, as % of original
(Bohling et al., 2004).
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Table 1: Percentage of epithelialisation (mean ± S.D)
bFGF-gelatin mean ± S.DDays Control mean ± S.D Keratin-Gelatin mean ± S.D
0 0 0
4 11.50 ± 4.11" 21.34 ± 9.20 b
8 28.00 ± 3.16' 51.52 ± 11.04 e
12 45.80 ± 6.04' 76.75 ± 4.03 b
16 60.94 ± 1.65' 86.52 ± 4.40b
20 80.94 ± 1.67' 98.99 ± 0.74<
0
17.87 ± 7.73 b




Values with different superscripts within a row differed significantly at P < 0.05
Table 2: Percentage of wound contraction (mean ± S.D)
Days Control mean ± S.D Keratin-Gelatin mean ± S.D bFGF-gelatin mean ± S.D
0 0 0 0
4 10.62 ± 4.10' 17.95 ± 12.23" 17.52 ± 9-
8 29.53 ± 4.57" 34.00 ± 6..31ab 37.00 ± 6.30b
12 50.76 ±1O.05 56.91 ± 14.63' 58.38 ± 0.82'
16 70.72 ± 1.72"b 75.22 ± 6.09b 69.71 ± 3.49-
20 76.89 ± 3.65' 88.23 ± 2.62< 80.14 ± 1.83b
Values with different superscripts within a row differed significantly at P < 0.05
Table 3: Percentage of total wound healing (mean ± S.D)
Days Control mean ± S.D Keratin-Gelatin mean ± S.D bFGF-gelatin mean ± S.D
0 0 0 0
4 28.72 ±12.46' 38.99 ± 6.68' 40.59 ± 7.45"
8 51.80 ± 6.36" 70.44 ± 7.37ab 66 ± 3.19b
12 67.68 ± 9.75 87.80 ± 12.46' 73.53 ± 3.72"
16 83.59 ± 2.8"b 96.64 ± 1.58b 86.20 ± 3.46"
20 89.45 ± 3.65' 99.55 ± 0.40< 96.98 ± 0.56b
Values with different superscripts within a row differed significantly at P < 0.05
Sterile cotton swabs were rolled over the wounds
and streaked on blood and MacConkey agar plates. The
colony growth was examined and identified by biochemi-
cal test after an incubation period of 24 hours.
Data analysis
Wound epithelialisation, contraction, and total
wound healing across treatment groups were compared
using repeated measures analysis of variance method
for days 0, 4,8,12, 16 and 20. Significant means were elu-
cidated using Duncan's multiple range test. All statisti-
cal tests were conducted at 95 % level of confidence.
RESULTS
On application, the keratin-gelatin and bFGF-gelatin
composite film adhered uniformly to the wound site. No
unabsorbed remnants were noticed during the next ap-
plication. InGroups I and ill, the wound colour was red
up to day 12 and pink in colour from day 16 and 20. Group
II showed bright beefy red colour up to day 12 and it was
red from day16 and 20. Mal-odour was observed up to
day 12 in Group I and ill. InGroup II, mild mal-odour was
observed up to day 8. Serous discharge was noticed up
to day 12 in Group I.No exudates were seen in Group II
throughout the study. Mild serous discharge was no-
ticed up to day 8 in Group ill.
Percentage of epithelialisation was consistently bet-
ter in Group II throughout the trial. The difference be-
tween Groups II and ill compared to Group I was evident
as early as day 4. The percentage of epithelialisation im-
proved dramatically from 21 % (day 4) to almost 99% On
day 20 in Group II. This was almost twice the value noted
for Group I until day 12. Group ill on the other hand,
demonstrated better than average epithelialisation
throughout the trial (Table 1).
Percentage of wound contraction was better in Group
ill up to day 12; however, it was best in Group II on day
16 and 20. The difference between Groups II and ill com-
pared to Group I was evident On day 8. Percentage of
wound contraction improved dramatically from 75 % (day
16) to almost 88 % on day 20 in Group II, but Group ill
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showed improvement from 17% (day-4) to almost 80%on
day 20. On the other hand, at the end of the trail, Group II
showed better wound contraction (Table 2).
Percentage of total wound healing was consistently
better in Group II throughout the trial. The difference
between Groups II and Illcompared to Group I was evi-
dent from day 8. Percentage of total wound healing im-
proved dramatically from 39% (day 4) to almost 99.5% on
day 20 in Group II. On the other hand Group II, demon-
strated better than average total wound healing through-
out the trial (Table 3).
On bacteriological examination, Staphylococcus
aureus, Pseudomonas, Escherichia coli, Proteus and
Klebsiella species were isolated from all the Groups.
DISCUSSION
In Groups II and Ill, application of keratin-gelatin
and bFGF-gelatin composite film was well tolerated by
the animals. Both the films are easy to apply on the wound
without any adverse reaction and were well accepted by
all the animals. Keratins contain no cellular materials so
they do not elicit any immune response (Dyke, 2005).
Keratin-gelatin composite film is of animal origin, as such
no reaction and rejection were observed and was well
accepted without any adverse reaction. Application of
keratin- gelatin and bFGF-gelatin composite film did not
show any adhesion of the gauze during wound dressing.
The colour of the wound bed in Groups I and Ill was
red while Group II showed bright beefy red color, which
indicates healthy granulation tissue with neovas-
cularisation, (James and Bayat, 2003) and resistance to
infection until the epithelial barrier is re-established (pope,
1993; Hosgood, 2003). The bright red color observed is
due to micro vascular network throughout the granula-
tion tissue (Tonnesen et al., 2000). Basic fibroblast growth
factor set the stage for angiogenesis during the first three
days of wound repair (Schaffer et al., 2004) and plays an
important role in granulation tissue formation and the
wound healing process (Takehara, 2000), but in the
present study Group Ill showed less angiogenesis com-
pared to Group II; this may be due to the fact that only
0.051lg/square centimeter ofbFGF-gelatin composite film
was incorporated in the film and this may be too low to
stimulate anticipated wound healing since it is dose de-
pendent (Ono, 2002). Granulation in all the cases was flat
without any exuberant nature; granulation tissue with a
smooth surface facilitates migration of epithelial cells
(Pope, 1993). On days 16 and 20, the granulation tissue
was observed to be pink in colour in Group I and Ill
which indicates the fmal stage of wound healing. InGroup
II the granulation tissue was red in colour due to
neovascularisation (James and Bayat, 2003).
Mal-odour was observed up to day 12 in Groups I
and Ill; however, In Group II, mild mal-odour was ob-
served up to day 8 which may be due to infection (James
and Bayat, 2003). The presence of bacterial infection was
the common cause for the mal-odour observed, because
all the wounds were infected. Serous discharge was no-
ticed up to day 12 in Group I and mild serous discharge
was noticed up to day 8 in Group Ill; subsequently, the
discharge was reduced because healthy vascular granu-
lation tissue is resistant to infection (Pope, 1993;
Hosgood, 2003). No exudates were seen in Group II
throughout the study because of the absorbent property
of keratin. Keratin powder can be used as a therapeutic
absorbent for skin applications (Jacksen et al., 2004).
Wound epithelialisation of Group II was consistently
better than Group I, and also better then Group Ill be-
cause the re-epithelialisation process in a full-thickness
wound is accelerated by the presence of keratinocyte
growth factor and its proliferation is essential for optimal
wound healing (Ghalbzouri et al., 2004). On day 4,
epithelialisation was significantly better in Groups II and
Ill, compared to Group I, because keratinocyte from the
wound margins began to migrate to form new epithelium
(Kirfel and Herzog, 2004). Keratinocyte plays an impor-
tant role in the renewal of epidermis (Ghalbzouri et al.,
2004).
The mean percentage of wound epithelialisation in
Group II was maximum between days 4 and 8 (30.18 %)
but in Groups Ill and I, it was between days 16 and 20
(27% and 20 %). A similar finding was reported by
Swaim et al. (1993), Bohling et al. (2004). Keratinocyte
growth factor is a potent specific growth factor for epi-
thelial cells and assists in re-epithelialisation (Werner et
al.; 1994). The percentage of epithelialisation was sig-
nificantly higher in Group II, quantity ofbFGF (0.0151lg/
cm') used was too low to produce significant results when
compared to keratin, because Ono, (2001) reported that
a dose of about 1 gram per cm is needed for significant
wound healing. Basic fibroblast growth factor is expen-
sive when compared to keratin which can be prepared
from poultry feathers.
The percentage of wound contraction on post
wound days 4, 8, 12 and 16 of Group II showed no signifi-
cant difference from Group I; this may be because of an
inherent property of fibroblasts that appears early in the
process of wound contraction which after some time do
not contract as forcefully as those that appear later
(Bohling et al., 2004). Schaffer et al. (2004) reported that
there is increased fibroblast activity of the body until
post-wound day 14. On days 8, 16 and 20, Group Ill was
significantly better than Group I since basic fibroblast
growth factor effectively accelerated wound fibroblast
proliferation (Kawai et al., 2000) and has a characteristic
myofibroblastic appearance which plays a critical role in
closure and healing (Cheng et al., 1999).
The mean percentage of wound contraction of Group
II on day 20 was significantly better than other two
groups; in open wounds, contraction becomes an impor-
tant feature and epithelialisation assumes a more predomi-
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nant role. However, the two processes are independent
of each other (Prost, 2003). All the groups showed maxi-
mum rates of contraction in the period between 8 and 12
post-wound days; similar findings have been reported
by Swaim et al. (1993); Bohling et al. (2004); Aljadyet
al. (2000) and Baie and Sheikh (2000).
The percentage of total wound healing of Group II
was significantly better then Group I and consistently
better than Group III because of more rapid
epithelialisation; there is a corresponding reduction in
area of exposed granulation tissue in the wound. (Bohling
et al., 2004). On day 20, among Groups IIand ill there
was no significant difference but healing was significantly
better than in Group I.Basic FGF is well known for pro-
moting the proliferation of almost all cells associated with
wound healing (Michiyo et al., 2005). Keratinocyte pro-
duces bFGF which participates in wound healing (Ono,
2002). All the groups showed maximum mean percent-
age of total wound healing from days 4 to 8; this is in
concurrence with the results of Bohling et al. (2004) but
differs from the findings of Swaim et al. (1993). Staphy-
lococcus aureus, Psudomonous, Klebsiella sp Escheri-
chia coli is the common infection in wounds (Kumar et
al.,2006). All wounds can be contaminated regardless of
precautions taken (Pope, 1993).
The present study shows that keratin-gelatin com-
posite film can be used as a wound healing stimulant to
promote healing of extensive wounds in animals. Keratins
are a family of structural proteins that provide the du-
rable overcoat to the skin and protect the deeper cells. It
is a biocompatible protein that does not interfere with
the body's normal immunologic response and can be used
in non healing chronic wounds which require a trigger to
stimulate the normal healing process.
CONCLUSION
Keratin can be a better wound healing biomaterial
in dogs. It can be used as a less expensive skin substitute
in order to stimulate and promote wound healing in ani-
mals.
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